Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2017

Open Access 01-12-2016 | Research

Validation of T2* in-line analysis for tissue iron quantification at 1.5 T

Authors: Mohammed H. Alam, Taigang He, Dominique Auger, Gillian C. Smith, Peter Drivas, Rick Wage, Cemil Izgi, Karen Symmonds, Andreas Greiser, Bruce S. Spottiswoode, Lisa Anderson, David Firmin, Dudley J. Pennell

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2017

Login to get access

Abstract

Background

There is a need for improved worldwide access to tissue iron quantification using T2* cardiovascular magnetic resonance (CMR). One route to facilitate this would be simple in-line T2* analysis widely available on MR scanners. We therefore compared our clinically validated and established T2* method at Royal Brompton Hospital (RBH T2*) against a novel work-in-progress (WIP) sequence with in-line T2* measurement from Siemens (WIP T2*).

Methods

Healthy volunteers (n = 22) and patients with iron overload (n = 78) were recruited (53 males, median age 34 years). A 1.5 T study (Magnetom Avanto, Siemens) was performed on all subjects. The same mid-ventricular short axis cardiac slice and transaxial slice through the liver were used to acquire both RBH T2* images and WIP T2* maps for each participant. Cardiac white blood (WB) and black blood (BB) sequences were acquired. Intraobserver, interobserver and interstudy reproducibility were measured on the same data from a subset of 20 participants.

Results

Liver T2* values ranged from 0.8 to 35.7 ms (median 5.1 ms) and cardiac T2* values from 6.0 to 52.3 ms (median 31 ms). The coefficient of variance (CoV) values for direct comparison of T2* values by RBH and WIP were 6.1–7.8 % across techniques. Accurate delineation of the septum was difficult on some WIP T2* maps due to artefacts. The inability to manually correct for noise by truncation of erroneous later echo times led to some overestimation of T2* using WIP T2* compared with the RBH T2*. Reproducibility CoV results for RBH T2* ranged from 1.5 to 5.7 % which were better than the reproducibility of WIP T2* values of 4.1–16.6 %.

Conclusions

Iron estimation using the T2* CMR sequence in combination with Siemens’ in-line data processing is generally satisfactory and may help facilitate global access to tissue iron assessment. The current automated T2* map technique is less good for tissue iron assessment with noisy data at low T2* values.
Literature
1.
go back to reference Pennell DJ, Udelson JE, Arai AE, et al. Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013;128:281–308.CrossRefPubMed Pennell DJ, Udelson JE, Arai AE, et al. Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013;128:281–308.CrossRefPubMed
2.
go back to reference Angelucci E, Barosi G, Camaschella C, Cappellini MD, Cazzola M, Galanello R, Marchetti M, Piga A, Tura S. Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica. 2008;93:741–52. Angelucci E, Barosi G, Camaschella C, Cappellini MD, Cazzola M, Galanello R, Marchetti M, Piga A, Tura S. Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica. 2008;93:741–52.
3.
go back to reference Ho P, Tay L, Lindeman R, Catley L, Bowden D. Australian guidelines for the assessment of iron overload and iron chelation in transfusion‐dependent thalassaemia major, sickle cell disease and other congenital anaemias. Intern Med J. 2011;41:516–24.CrossRefPubMed Ho P, Tay L, Lindeman R, Catley L, Bowden D. Australian guidelines for the assessment of iron overload and iron chelation in transfusion‐dependent thalassaemia major, sickle cell disease and other congenital anaemias. Intern Med J. 2011;41:516–24.CrossRefPubMed
4.
go back to reference Anderson LJ, Holden S, Davies B, et al. Cardiovascular T2* (T2 star) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–9.CrossRefPubMed Anderson LJ, Holden S, Davies B, et al. Cardiovascular T2* (T2 star) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–9.CrossRefPubMed
5.
go back to reference Westwood M, Anderson LJ, Firmin DN, et al. A single breath–hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging. 2003;18:33–9.CrossRefPubMed Westwood M, Anderson LJ, Firmin DN, et al. A single breath–hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging. 2003;18:33–9.CrossRefPubMed
6.
go back to reference Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ. Thalassemia International Federation Heart T2* Investigators. Multi–center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica. 2006;91:1388–91.PubMed Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ. Thalassemia International Federation Heart T2* Investigators. Multi–center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica. 2006;91:1388–91.PubMed
7.
go back to reference Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, Westwood MA, Anderson LJ, Pennell DJ. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009;120:1961–8. Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, Westwood MA, Anderson LJ, Pennell DJ. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009;120:1961–8.
8.
go back to reference Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Roughton M, Assomull R, Nair SV, Walker JM, Pennell DJ. A randomized, placebo controlled, double blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation. 2007;115:1876–84.CrossRefPubMed Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Roughton M, Assomull R, Nair SV, Walker JM, Pennell DJ. A randomized, placebo controlled, double blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation. 2007;115:1876–84.CrossRefPubMed
10.
go back to reference He T, Smith GC, Gatehouse PD, Mohiaddin RH, Firmin DN, Pennell DJ. On using T2 to assess extrinsic magnetic field inhomogeneity effects on T2* measurements in myocardial siderosis in thalassemia. Magn Reson Med. 2009;61:501–6.CrossRefPubMed He T, Smith GC, Gatehouse PD, Mohiaddin RH, Firmin DN, Pennell DJ. On using T2 to assess extrinsic magnetic field inhomogeneity effects on T2* measurements in myocardial siderosis in thalassemia. Magn Reson Med. 2009;61:501–6.CrossRefPubMed
11.
go back to reference Feng Y, He T, Carpenter JP, et al. In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major. J Magn Reson Imaging. 2013;38:588–93.CrossRefPubMed Feng Y, He T, Carpenter JP, et al. In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major. J Magn Reson Imaging. 2013;38:588–93.CrossRefPubMed
12.
go back to reference Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42.CrossRefPubMedPubMedCentral Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42.CrossRefPubMedPubMedCentral
13.
go back to reference Carpenter JP, Roughton M, Pennell DJ. International survey of T2* cardiovascular magnetic resonance in beta thalassemia major. Haematologica. 2013;98:1368–74.CrossRefPubMedPubMedCentral Carpenter JP, Roughton M, Pennell DJ. International survey of T2* cardiovascular magnetic resonance in beta thalassemia major. Haematologica. 2013;98:1368–74.CrossRefPubMedPubMedCentral
14.
go back to reference Kirk P, He T, Anderson LJ, et al. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging. 2010;32:315–9.CrossRefPubMedPubMedCentral Kirk P, He T, Anderson LJ, et al. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging. 2010;32:315–9.CrossRefPubMedPubMedCentral
15.
go back to reference He T, Gatehouse PD, Kirk P, et al. Black–blood T2* technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging. 2007;25:1205–9.CrossRefPubMed He T, Gatehouse PD, Kirk P, et al. Black–blood T2* technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging. 2007;25:1205–9.CrossRefPubMed
16.
go back to reference Smith GC, Carpenter JP, He T, Alam MH, Firmin DN, Pennell DJ. Value of black blood T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13:21.CrossRefPubMedPubMedCentral Smith GC, Carpenter JP, He T, Alam MH, Firmin DN, Pennell DJ. Value of black blood T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13:21.CrossRefPubMedPubMedCentral
17.
go back to reference Salerno M, Kramer CM. Advances in parametric mapping with CMR imaging. J Am Coll Cardiol Img. 2013;6:806–22.CrossRef Salerno M, Kramer CM. Advances in parametric mapping with CMR imaging. J Am Coll Cardiol Img. 2013;6:806–22.CrossRef
18.
go back to reference Feng Y, He T, Feng M, et al. Improved pixel-by-pixel MRI R2* relaxometry by nonlocal means. Magn Reson Med. 2014;72:260–8.CrossRefPubMed Feng Y, He T, Feng M, et al. Improved pixel-by-pixel MRI R2* relaxometry by nonlocal means. Magn Reson Med. 2014;72:260–8.CrossRefPubMed
19.
go back to reference Kellman P, Xue H, Spottiswoode BS, Sandino CM, Hansen MS, Abdel-Gadir A, Treibel TA, Rosmini S, Mancini C, Bandettini WP, McGill LA, Gatehouse P, Moon JC, Pennell DJ, Arai AE. Free-breathing T2* mapping using respiratory motion corrected averaging. J Cardiovasc Magn Reson. 2015;17:3. Kellman P, Xue H, Spottiswoode BS, Sandino CM, Hansen MS, Abdel-Gadir A, Treibel TA, Rosmini S, Mancini C, Bandettini WP, McGill LA, Gatehouse P, Moon JC, Pennell DJ, Arai AE. Free-breathing T2* mapping using respiratory motion corrected averaging. J Cardiovasc Magn Reson. 2015;17:3.
20.
go back to reference Jin M, da Silveira JS, Jolly MP, Firmin DN, Mathew G, Lamba N, Subramanian S, Pennell DJ, Raman SV, Simonetti OP. Free-Breathing Myocardial T2* Mapping using GRE-EPI and automatic non-rigid motion correction. J Cardiovasc Magn Reson 2015. (In press) Jin M, da Silveira JS, Jolly MP, Firmin DN, Mathew G, Lamba N, Subramanian S, Pennell DJ, Raman SV, Simonetti OP. Free-Breathing Myocardial T2* Mapping using GRE-EPI and automatic non-rigid motion correction. J Cardiovasc Magn Reson 2015. (In press)
21.
go back to reference Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123:1519–28.CrossRefPubMedPubMedCentral Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123:1519–28.CrossRefPubMedPubMedCentral
Metadata
Title
Validation of T2* in-line analysis for tissue iron quantification at 1.5 T
Authors
Mohammed H. Alam
Taigang He
Dominique Auger
Gillian C. Smith
Peter Drivas
Rick Wage
Cemil Izgi
Karen Symmonds
Andreas Greiser
Bruce S. Spottiswoode
Lisa Anderson
David Firmin
Dudley J. Pennell
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2017
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/s12968-016-0243-4

Other articles of this Issue 1/2017

Journal of Cardiovascular Magnetic Resonance 1/2017 Go to the issue